Luzón-Toro, Berta
Villalba-Benito, Leticia
Fernández, Raquel María
Torroglosa, Ana
Antiñolo, Guillermo
Borrego, Salud https://orcid.org/0000-0002-2513-6161
Funding for this research was provided by:
Instituto de Salud Carlos III.Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future"). (PI16/0142)
Consejería de Salud, Junta de Andalucía (PEER-0470-2019)
Instituto de Salud Carlos III (ES).Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future"). (PI19/01550)
Article History
Received: 14 July 2020
Accepted: 22 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: A written informed consent was obtained from all the participants for clinical and molecular genetic studies, after a full explanation of the purpose and nature of all procedures used. The study was approved by the Ethics Committee for clinical research in the University Hospital Virgen del Rocío (Seville, Spain) and complies with the tenets of the declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.